Palmar Hyperhidrosis Treatment in Korea: Botox, Iontophoresis, and Surgical Options

Palmar hyperhidrosis — excessive sweating of the hands — is a quality-of-life condition that affects handshakes, paper handling, electronics use, and personal interactions. Korean dermatology offers comprehensive treatment options. This guide covers the practical hierarchy from non-invasive iontophoresis to Botox to surgical ETS.

What palmar hyperhidrosis is

  • Excessive sweating of palms beyond normal physiological need.
  • Often genetic component.
  • Triggered or worsened by stress, anxiety, heat.
  • Impacts daily activities — handshakes, writing, typing, electronics, intimate contact.
  • Often coexists with axillary or other site hyperhidrosis.

Severity assessment

The Hyperhidrosis Disease Severity Scale (HDSS):

  • 1: sweating never noticeable; no daily activities affected.
  • 2: sweating tolerable but sometimes interferes.
  • 3: sweating barely tolerable; frequently interferes.
  • 4: sweating intolerable; always interferes.

Treatment typically appropriate at HDSS 3–4; HDSS 2 may benefit from less aggressive interventions.

Treatment hierarchy

Tier 1: Topical antiperspirants

  • Aluminum chloride solutions (clinical strength).
  • Apply to dry skin overnight.
  • Effective for mild cases.
  • First-line before more invasive options.
  • Often inadequate for moderate-to-severe cases.

Tier 2: Iontophoresis

  • Mild electrical current passed through tap water with hands submerged.
  • Approximately 10 sessions to achieve initial control.
  • Maintenance 1–2 sessions weekly thereafter.
  • Approximately 85% success rate in some studies.
  • Home devices available for ongoing maintenance.
  • Cost-effective long-term solution.

Tier 3: Botulinum toxin (Botox)

  • 50–100 units injected in grid pattern across palm.
  • 15–30 minute procedure.
  • Topical numbing or nerve block recommended (palmar injections are uncomfortable).
  • 80–90% effective in reducing sweat production.
  • Effect begins at 5–7 days; peaks at 2 weeks.
  • Duration: 4–6 months typically (shorter than axillary).
  • Repeat injections needed for sustained benefit.

Tier 4: Endoscopic Thoracic Sympathectomy (ETS)

  • Surgical interruption of sympathetic nerves controlling palm sweat.
  • Permanent solution.
  • Significant compensatory sweating risk (30–60% of patients) — sometimes worse than original problem.
  • Reserved for severe cases failing other treatments.
  • Detailed informed consent essential.
  • Performed at hospital-grade facility.

Why palm Botox differs from underarm

  • Palmar skin is thicker; injection more uncomfortable.
  • Higher density of injection points needed.
  • Local nerve blocks (median, ulnar, radial) often used.
  • Effect duration shorter than axillary (4–6 months vs. 4–8 months).
  • Possible temporary hand weakness if injection technique imprecise.
  • Functional considerations for hand-intensive professions.

The Korean treatment approach

Typical Korean dermatology hierarchy:

  1. Topical antiperspirant trial (4 weeks).
  2. Iontophoresis (10 sessions if topical inadequate).
  3. Botox if iontophoresis insufficient or impractical.
  4. Combination therapy (iontophoresis maintenance + occasional Botox).
  5. ETS surgery only for severe refractory cases.

Combination strategies

  • Iontophoresis + Botox: Botox for major events, iontophoresis for daily maintenance.
  • Topical + Botox: topical antiperspirant maintains effect between Botox sessions.
  • Combined palmar + axillary Botox: common for patients with multiple-site hyperhidrosis.

The Botox session experience

  • Pre-procedure consultation and consent.
  • Topical numbing cream 30 minutes.
  • Sometimes nerve block injections for additional pain control.
  • Grid-pattern injections across palm (50–100 sites).
  • Mild discomfort; tolerable with proper anesthesia.
  • Post-injection palm soreness for hours.
  • Light hand activities only for 24 hours.

Home iontophoresis devices

Many Korean dermatologists support home iontophoresis after initial in-clinic course:

  • Devices available for $200–$500.
  • Maintenance protocol 1–2 sessions weekly.
  • Cost-effective long-term.
  • Supplements or replaces Botox for some patients.

Risks specific to palmar treatment

  • Palmar Botox: temporary hand weakness, grip reduction, fine motor impairment.
  • Iontophoresis: mild electrical sensation; rare skin irritation.
  • ETS: compensatory sweating elsewhere on body; rare but serious complications.
  • All treatments: incomplete response in some patients.

For specific occupations

Hand-intensive professions need careful consideration:

  • Musicians, surgeons, athletes: palmar Botox may temporarily affect fine motor function.
  • Time treatments around critical performances or schedules.
  • Iontophoresis preferred for some patients due to no impact on grip strength.

What to ask in your consultation

  1. What is the severity of my hyperhidrosis (HDSS score)?
  2. What is the appropriate first-line approach?
  3. If Botox: how is pain managed during injection?
  4. What is the expected duration of effect?
  5. Should I consider iontophoresis (with potential home device)?
  6. Is ETS appropriate, given the compensatory sweating risk?

Pricing in Gangnam (2026, USD)

  • Iontophoresis per session: $25–$80.
  • 10-session iontophoresis package: $200–$700.
  • Home iontophoresis device: $200–$500.
  • Palmar Botox (both hands): $400–$1,500.
  • Combined palmar + axillary Botox: $600–$2,000.
  • ETS surgery: $4,500–$9,000 (hospital-grade procedure).

For international patients

  • Botox produces results before flying home.
  • Iontophoresis course possible during extended trip with home device for continuation.
  • ETS requires hospital-grade trip planning with longer recovery.
  • Continuity treatment depends on home-country provider availability.

The honest framing

Palmar hyperhidrosis treatment in Korea offers a comprehensive hierarchy from non-invasive iontophoresis to surgical ETS. The patients who achieve best outcomes typically work through the hierarchy: topical first, iontophoresis if inadequate, Botox if ongoing concern, ETS only if other options fail. ETS\'s compensatory sweating risk makes it an option of last resort. Most patients find quality-of-life benefit from non-surgical options without the irreversibility of ETS. Match treatment intensity to severity and the result is meaningful improvement in daily life.

← 목록으로